274 related articles for article (PubMed ID: 12856213)
1. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy.
De Waele JJ; Vogelaers D; Blot S; Colardyn F
Clin Infect Dis; 2003 Jul; 37(2):208-13. PubMed ID: 12856213
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and outcome of fungal infection in patients with severe acute pancreatitis.
Kochhar R; Ahammed SK; Chakrabarti A; Ray P; Sinha SK; Dutta U; Wig JD; Singh K
J Gastroenterol Hepatol; 2009 May; 24(5):743-7. PubMed ID: 19220667
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
Sohn HS; Lee TJ; Kim J; Kim D
Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
[TBL] [Abstract][Full Text] [Related]
4. Fungal infections in severe acute pancreatitis.
Kochhar R; Noor MT; Wig J
J Gastroenterol Hepatol; 2011 Jun; 26(6):952-9. PubMed ID: 21299617
[TBL] [Abstract][Full Text] [Related]
5. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
[TBL] [Abstract][Full Text] [Related]
6. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
Isaacs D
Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
[TBL] [Abstract][Full Text] [Related]
7. The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis.
Ho KM; Lipman J; Dobb GJ; Webb SA
Crit Care; 2005; 9(6):R710-7. PubMed ID: 16280069
[TBL] [Abstract][Full Text] [Related]
8. Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis, and treatment.
Goldstein DJ; el-Amir NG; Ashton RC; Catanese K; Rose RA; Levin HR; Oz MC
ASAIO J; 1995; 41(4):873-5. PubMed ID: 8589469
[TBL] [Abstract][Full Text] [Related]
9. Impact of fluconazole administration on outcomes in critically ill patients.
Garrelts JC; Schroeder TR; Harrison PB
Ann Pharmacother; 2004 Oct; 38(10):1588-92. PubMed ID: 15340132
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotic prophylaxis in acute pancreatitis].
Degowska M; Rydzewska G
Pol Merkur Lekarski; 2007 May; 22(131):465-8. PubMed ID: 17679397
[TBL] [Abstract][Full Text] [Related]
11. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
Manzoni P; Arisio R; Mostert M; Leonessa M; Farina D; Latino MA; Gomirato G
Pediatrics; 2006 Jan; 117(1):e22-32. PubMed ID: 16326690
[TBL] [Abstract][Full Text] [Related]
14. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors for invasive fungal infections during intensive chemotherapy of acute leukemia--retrospective study].
Zupanić-Krmek D; Nemet D; Mrsić M; Bogdanić V; Labar B; Jandrlić M; Kalenić S
Acta Med Croatica; 2004; 58(4):275-84. PubMed ID: 15700683
[TBL] [Abstract][Full Text] [Related]
16. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
17. Rational use of antimicrobials in patients with severe acute pancreatitis.
De Waele JJ
Semin Respir Crit Care Med; 2011 Apr; 32(2):174-80. PubMed ID: 21506053
[TBL] [Abstract][Full Text] [Related]
18. Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis.
Kaya Z; Gursel T; Kocak U; Aral YZ; Kalkanci A; Albayrak M
Pediatr Blood Cancer; 2009 Apr; 52(4):470-5. PubMed ID: 19058205
[TBL] [Abstract][Full Text] [Related]
19. [Nosocomial fungal infections, analysis of 149 cases].
Liu ZY; Sheng RY; Li XL; Li TS; Wang AX
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):399-402. PubMed ID: 12820917
[TBL] [Abstract][Full Text] [Related]
20. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
